1500005I dynport vaccine company, LLC; to 15-0109.B1.0052--05 base; biod can 8470038; $59,564
Ended Awarded Last action
- Contract number
- HHSN27200003
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,757,168
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $1,757,167.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$639 | |
| Funding Only Action | -$8,072 | |
| Supplemental Agreement for work within scope | -$12,074 | |
| Funding Only Action | $3,485 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $184,229 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,420,964 | |
| Supplemental Agreement for work within scope | $109,711 | |
| Original award | $59,564 |
Show all 11
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Dynport Vaccine Company LLC on August 19, 2016, under the Therapeutics Against Infectious Diseases Phase 1 IDIQ to administrate de-obligation of unexpended and expiring fiscal year 2021 funding in preparation for the September 30, 2026, closing of the period of availability.
The order carries a ceiling value of $1.757 million and is priced on a cost-plus-fixed-fee basis. Place of performance is Durham, NC. Ultimate completion date is August 30, 2023. The order obligated $59,564 in this action. Service Contract Inventory reporting for FY2020 showed $84 thousand invoiced with no subcontractors; Dynport self-performed all reported work.
Quick answers
Who was awarded contract HHSN27200003?
HHSN27200003 was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 19, 2016.
How much is contract HHSN27200003 worth?
The government has obligated $1,757,168 on HHSN27200003.
Is contract HHSN27200003 an order under another contract?
Yes. HHSN27200003 is a delivery order under HHSN272201500005I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract HHSN27200003 competed?
The extent of competition for HHSN27200003 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award